{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:30:33Z","timestamp":1781659833799,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.tcm.2020.09.004","type":"journal-article","created":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T11:02:36Z","timestamp":1601722956000},"page":"427-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Interatrial shunt devices for the treatment of heart failure"],"prefix":"10.1016","volume":"31","author":[{"given":"Sitaramesh","family":"Emani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Burkhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Lilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tcm.2020.09.004_bib0001","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"14","key":"10.1016\/j.tcm.2020.09.004_bib0002","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMsa0803563","article-title":"Rehospitalizations among patients in the medicare fee-for-service program","volume":"360","author":"Jencks","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.tcm.2020.09.004_bib0003","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2012.08.1029","article-title":"Patient selection for ventricular assist devices: a moving target","volume":"61","author":"Miller","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.tcm.2020.09.004_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006267","article-title":"Stepping out of the left ventricle's shadow: time to focus on the left atrium in heart failure with preserved ejection fraction","volume":"10","author":"Freed","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"issue":"27","key":"10.1016\/j.tcm.2020.09.004_bib0005","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2020.09.004_bib0006","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.tcm.2020.09.004_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jjcc.2013.02.017","article-title":"Heart failure: what does ejection fraction have to do with it?","volume":"62","author":"Iwano","year":"2013","journal-title":"J Cardiol"},{"issue":"4","key":"10.1016\/j.tcm.2020.09.004_bib0008","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11936-018-0623-1","article-title":"Current management and future directions of heart failure with preserved ejection fraction: a contemporary review","volume":"20","author":"Krittanawong","year":"2018","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"8","key":"10.1016\/j.tcm.2020.09.004_bib0009","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jchf.2018.03.006","article-title":"Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction","volume":"6","author":"Tsao","year":"2018","journal-title":"JACC Heart Failure"},{"issue":"5","key":"10.1016\/j.tcm.2020.09.004_bib0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/heartjnl-2016-310790","article-title":"Heart failure with preserved ejection fraction: controversies, challenges and future directions","volume":"104","author":"Zakeri","year":"2018","journal-title":"Heart"},{"issue":"15","key":"10.1016\/j.tcm.2020.09.004_bib0011","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.tcm.2020.09.004_bib0012","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.tcm.2020.09.004_bib0013","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1161\/CIRCULATIONAHA.120.047275","article-title":"Response by Jackson et\u00a0al. to letter regarding article, \"Effects of Sacubitril-Valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HF","volume":"142","author":"Jackson","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.tcm.2020.09.004_bib0014","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0002-9149(94)90012-4","article-title":"Assessing risk by hemodynamic profile in patients awaiting cardiac transplantation","volume":"73","author":"Morley","year":"1994","journal-title":"Am J Cardiol"},{"issue":"19","key":"10.1016\/j.tcm.2020.09.004_bib0015","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/0002-9149(90)91166-4","article-title":"Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy","volume":"66","author":"Stevenson","year":"1990","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.tcm.2020.09.004_bib0016","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jacc.2007.10.061","article-title":"Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study","volume":"51","author":"Bourge","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.tcm.2020.09.004_bib0017","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/CIRCHEARTFAILURE.109.923300","article-title":"Chronic ambulatory intracardiac pressures and future heart failure events","volume":"3","author":"Stevenson","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"9766","key":"10.1016\/j.tcm.2020.09.004_bib0018","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"issue":"10017","key":"10.1016\/j.tcm.2020.09.004_bib0019","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(15)00723-0","article-title":"Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial","volume":"387","author":"Abraham","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.tcm.2020.09.004_bib0020","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/CIRCHEARTFAILURE.113.001229","article-title":"Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction","volume":"7","author":"Adamson","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.tcm.2020.09.004_bib0021","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/01.CIR.42.1.65","article-title":"Relationship of the pulmonary artery end-diastolic pressure to the left ventricular end-diastolic and mean filling pressures in patients with and without left ventricular dysfunction","volume":"42","author":"Falicov","year":"1970","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.tcm.2020.09.004_bib0022","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ejhf.976","article-title":"Resting and exercise haemodynamics in relation to six-minute walk test in patients with heart failure and preserved ejection fraction","volume":"20","author":"Wolsk","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.tcm.2020.09.004_bib0023","doi-asserted-by":"crossref","DOI":"10.1007\/s12265-018-9856-3","article-title":"A novel wireless left atrial pressure monitoring system for patients with heart failure, first ex-vivo and animal experience","author":"Perl","year":"2019","journal-title":"J Cardiovasc Transl Res"},{"issue":"5","key":"10.1016\/j.tcm.2020.09.004_bib0024","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction","volume":"3","author":"Borlaug","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"44","key":"10.1016\/j.tcm.2020.09.004_bib0025","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/eurheartj\/ehu315","article-title":"Pulmonary capillary wedge pressure during exercise and long-term mortality in patients with suspected heart failure with preserved ejection fraction","volume":"35","author":"Dorfs","year":"2014","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.tcm.2020.09.004_bib0026","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.7326\/0003-4819-33-4-1031","article-title":"Longevity in extensive organic heart lesions: a case of Lutembacher's syndrome in a man aged 72","volume":"33","author":"Askey","year":"1950","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.tcm.2020.09.004_bib0027","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0003-4975(10)63484-4","article-title":"Atrial septal defect: acute left heart failure after surgical closure","volume":"25","author":"Beyer","year":"1978","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.tcm.2020.09.004_bib0028","first-page":"177","article-title":"Masked left ventricular restriction in elderly patients with atrial septal defects: a contraindication for closure?","volume":"52","author":"Ewert","year":"2001","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.tcm.2020.09.004_bib0029","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1097\/01.CCM.0000239113.02836.F1","article-title":"Decompression of the left atrium during extracorporeal membrane oxygenation using a transseptal cannula incorporated into the circuit","volume":"34","author":"Aiyagari","year":"2006","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.tcm.2020.09.004_bib0030","first-page":"70","article-title":"Percutaneous balloon atrial septostomy on top of venoarterial extracorporeal membrane oxygenation results in safe and effective left heart decompression","volume":"7","author":"Baruteau","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"2","key":"10.1016\/j.tcm.2020.09.004_bib0031","first-page":"197","article-title":"Bedside transseptal balloon dilation atrial septostomy for decompression of the left heart during extracorporeal membrane oxygenation","volume":"46","author":"Johnston","year":"1999","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.tcm.2020.09.004_bib0032","first-page":"179","article-title":"Blade and balloon atrial septostomy for left heart decompression in patients with severe ventricular dysfunction on extracorporeal membrane oxygenation","volume":"46","author":"Seib","year":"1999","journal-title":"Catheter Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.tcm.2020.09.004_bib0033","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.jacc.2018.08.1029","article-title":"2018 AHA\/ACC guideline for the management of adults with congenital heart disease: a report of the american college of cardiology\/American heart association task force on clinical practice guidelines","volume":"73","author":"Stout","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.tcm.2020.09.004_bib0034","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cardfail.2014.01.005","article-title":"Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure","volume":"20","author":"Kaye","year":"2014","journal-title":"J Card Fail"},{"issue":"10025","key":"10.1016\/j.tcm.2020.09.004_bib0035","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0140-6736(16)00704-2","article-title":"A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial","volume":"387","author":"Hasenfuss","year":"2016","journal-title":"Lancet"},{"issue":"43","key":"10.1016\/j.tcm.2020.09.004_bib0036","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1093\/eurheartj\/ehw241","article-title":"Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction","volume":"37","author":"Borlaug","year":"2016","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.tcm.2020.09.004_bib0037","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003662","article-title":"One-year outcomes after transcatheter insertion of an interatrial shunt device for the management of heart failure with preserved ejection fraction","volume":"9","author":"Kaye","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"7","key":"10.1016\/j.tcm.2020.09.004_bib0038","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003025","article-title":"Transcatheter interatrial shunt device for the treatment of heart failure: rationale and design of the randomized trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I)","volume":"9","author":"Feldman","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.tcm.2020.09.004_bib0039","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.117.032094","article-title":"Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): a phase 2, randomized, sham-controlled trial","volume":"137","author":"Feldman","year":"2018","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.tcm.2020.09.004_bib0040","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/jamacardio.2018.2936","volume":"3","author":"Shah","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.tcm.2020.09.004_bib0041","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ahj.2019.10.015","article-title":"Transcatheter interatrial shunt device for the treatment of heart failure: rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II)","volume":"226","author":"Berry","year":"2020","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.tcm.2020.09.004_bib0042","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.tcm.2020.09.004_bib0043","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jcin.2015.02.009","article-title":"Left atrial decompression using unidirectional left-to-right interatrial shunt: initial experience in treating symptomatic heart failure with preserved ejection fraction with the W-wave device","volume":"8","author":"Amat-Santos","year":"2015","journal-title":"JACC Cardiovasc Intervent"},{"issue":"22","key":"10.1016\/j.tcm.2020.09.004_bib0044","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.jcin.2018.07.001","article-title":"Interatrial Shunting for heart failure: early and late results from the first-in-human experience with the V-wave system","volume":"11","author":"Rodes-Cabau","year":"2018","journal-title":"JACC Cardiovasc Intervent"},{"issue":"1\u20132","key":"10.1016\/j.tcm.2020.09.004_bib0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/24748706.2017.1326647","article-title":"Cardiac unloading with an implantable interatrial shunt in heart failure: serial observations in an ovine model of ischemic cardiomyopathy","volume":"1","author":"Eigler","year":"2017","journal-title":"Struct Heart"},{"issue":"10025","key":"10.1016\/j.tcm.2020.09.004_bib0046","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(16)00585-7","article-title":"Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study","volume":"387","author":"Del Trigo","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.tcm.2020.09.004_bib0047","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4244\/EIJY15M07_08","article-title":"Implantable atrial flow regulator for severe, irreversible pulmonary arterial hypertension","volume":"11","author":"Patel","year":"2015","journal-title":"EuroIntervention"},{"issue":"7","key":"10.1016\/j.tcm.2020.09.004_bib0048","first-page":"1145","article-title":"Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension","volume":"90","author":"Rajeshkumar","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2020.09.004_bib0049","series-title":"HFSA 20th Annual Scientific Meeting","article-title":"Hemodynamic monitoring in advanced heart failure: results from the LAPTOP-HF trial","author":"Abraham","year":"2016"},{"issue":"5","key":"10.1016\/j.tcm.2020.09.004_bib0050","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2217\/fca.09.30","article-title":"Late complications of transcatheter closure of patent foramen ovale: new technology and new outcomes","volume":"5","author":"Staubach","year":"2009","journal-title":"Future Cardiol"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173820301237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173820301237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T05:00:41Z","timestamp":1760936441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173820301237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1050173820301237"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2020.09.004","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interatrial shunt devices for the treatment of heart failure","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2020.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}